For candidates wondering about the financial side of their protocol in the context of new employment benefits, the guides on FSA coverage for semaglutide and HSA coverage for GLP-1 medications are relevant to understanding how new employer benefit plans might cover ongoing treatment
The FDA recently approved the Wegovy pill, an oral semaglutide option that provides flexibility for patients preferring not to use injections
"Any promotional activity, including so-called awareness campaigns that function as a surrogate advertisement for prescription-only drugs, shall be viewed seriously and may be treated as an irrational or misleading marketing practice," the advisory stated
Upper arm injection site: when you need a third option The back of the upper arm is the third approved injection site for tirzepatide
Once inside your body, the semaglutide signals different organs and brains to reduce appetite, slow gastric emptying, and increase insulin secretion
Though there isnt a definitive timeline for how long GLP-1-related nausea might persist, nausea is common within the first eight to 12 weeks of treatment because thats when you increase the dose of your medication